about
Telomere status in chronic lymphocytic leukemia with TP53 disruption.ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisGene dosage methods as diagnostic tools for the identification of chromosome abnormalities.Interleukin-6 gene amplification and shortened survival in glioblastoma patients.TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer.Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia.Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.De novo 2q36.1q36.3 interstitial deletion involving the PAX3 and EPHA4 genes in a fetus with spina bifida and cleft palate.Prenatal ultrasound diagnosis of a 48,XXYY syndrome.De novo unbalanced translocation 2;4 characterized by metaphase CGH and array CGH in a child with mental retardation and dysmorphic features.Prenatal detection of cryptic rearrangements by multiplex ligation probe amplification in fetuses with ultrasound abnormalities.Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.Telomeres and chromosomal instability in chronic lymphocytic leukemia.Familial deletion 11q14.3-q22.1 without apparent phenotypic consequences: a haplosufficient 8.5 Mb region14q deletions are associated with trisomy 12,NOTCH1mutations and unmutatedIGHVgenes in chronic lymphocytic leukemia and small lymphocytic lymphomaGain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stagesOutcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia“Double-hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gainLow MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemiaLarsen-like phenotype associated with partial trisomy 3p and monosomy 5p[Physiopathological, diagnostic and therapeutic impacts of chromosomal translocations in hematological malignancies]Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia
P50
Q36093789-B07877A5-9D32-4713-BB76-9BCD5961050BQ36175526-771DA632-A19A-429C-B43F-600AAD94C03CQ37177824-60DE57F1-3B39-4D02-84DE-941EDC83D363Q42549981-B0FFCAEF-797E-4440-9222-230CCC0E4B2BQ44378342-AB6CA418-27F7-4FA9-BF80-3A7E7A7ED5F1Q45746049-8F093B90-1632-406F-925A-246B1A6C02BFQ47678487-EC25B9E7-9E40-4CB3-AAEF-FE6E640D26FAQ50668904-223B3FC7-E037-4BB8-A5C5-427D64129F41Q50755101-F883A69A-79E8-4672-97FE-876CEA0B7572Q51825088-8671DA4C-B961-44F5-A993-96DE13D9149BQ51851557-04297603-5788-4265-99C1-47C627BC5F92Q52836237-9334A518-2696-4499-BB45-CE25156062B6Q54491927-E337F39B-CCE5-459F-877F-AD8A7EB59917Q57132446-17793597-81C3-4951-A2F8-DB9D2192C74FQ58041694-629B4C5B-F401-44DD-8648-D55908CA6601Q58041722-B550B803-A844-4AAD-908B-7F7F3F393BA1Q58100077-7A7969F5-6957-48E5-A642-E7B7121CF46EQ61772115-EB4197C0-57A7-424F-9BB0-396108A027B4Q80113979-F765A981-E67A-4CA7-B35B-7A23AE7B12F3Q80598427-05A4AE98-ADFC-4E0F-B3E9-6AB75E057C65Q82891646-0B088211-2C1B-408D-912E-E20E0D6D4E17Q90680132-F4BF6817-46C8-4694-A197-18716E48D9EE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
L Véronèse
@en
L Véronèse
@nl
type
label
L Véronèse
@en
L Véronèse
@nl
prefLabel
L Véronèse
@en
L Véronèse
@nl
P31
P496
0000-0002-4414-7974